Progress Toward Rubella Elimination - Western Pacific Region, 2000-2019.
Journal
MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429
Informations de publication
Date de publication:
19 Jun 2020
19 Jun 2020
Historique:
entrez:
20
6
2020
pubmed:
20
6
2020
medline:
23
6
2020
Statut:
epublish
Résumé
Rubella is the leading vaccine-preventable cause of birth defects. Rubella typically manifests as a mild febrile rash illness; however, infection during pregnancy, particularly during the first trimester, can result in miscarriage, fetal death, or a constellation of malformations known as congenital rubella syndrome (CRS), commonly including one or more visual, auditory, or cardiac defects (1). In 2012, the Regional Committee of the World Health Organization (WHO) Western Pacific Region (WPR)* committed to accelerate rubella control, and in 2017, resolved that all countries or areas (countries) in WPR should aim for rubella elimination
Identifiants
pubmed: 32555136
doi: 10.15585/mmwr.mm6924a4
pmc: PMC7302473
doi:
Substances chimiques
Rubella Vaccine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
744-750Déclaration de conflit d'intérêts
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Références
Western Pac Surveill Response J. 2016 Feb 03;7(1):10-13
pubmed: 27757248
Vaccine. 2014 Dec 5;32(51):6927-6933
pubmed: 25444818
Bull World Health Organ. 2002;80(7):585-91
pubmed: 12163924
Epidemiol Infect. 2001 Oct;127(2):297-303
pubmed: 11693507
MMWR Morb Mortal Wkly Rep. 2018 May 04;67(17):491-495
pubmed: 29723171